Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

Central serous chorioretinopathy associated with low dose systemic corticosteroid treatment of Behcet's disease

베체트병 환자에서 저용량 스테로이드 사용과 관련하여 발생한 중심성장액맥락망막병증

  • Cha, Sungwook (Department of Internal Medicine, Busan St.Mary's Hospial) ;
  • Kim, Kyung Jin (Department of Internal Medicine, Busan St.Mary's Hospial) ;
  • Kweon, Seongmin (Department of Internal Medicine, Busan St.Mary's Hospial) ;
  • Lee, Sinae (Department of Internal Medicine, Busan St.Mary's Hospial) ;
  • Min, Byungchul (Department of Internal Medicine, Busan St.Mary's Hospial) ;
  • Kim, Eunsung (Department of Internal Medicine, Busan St.Mary's Hospial) ;
  • Lee, Jungwook (Department of Internal Medicine, Busan St.Mary's Hospial)
  • Received : 2016.02.24
  • Accepted : 2016.06.23
  • Published : 2017.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Central serous chorioretinopathy may induce poor eyesight and serous retinal detachment. However, its exact cause has not been well established thus far. It can be associated with systemic high-dose corticosteroid treatment mainly for young and middle-aged men and may spontaneously regress or recur after withdrawal from corticosteroid. After corticosteroid administration for Behcet's disease, it is necessary to identify any ocular symptoms. Behcet's disease can lead to the development of ocular complications, such as uveitis, hypopyon, retinal vasculitis, optic neuritis, angiogenesis, secondary cataract, and glaucoma. It is possible to diagnose any of these complications via optical coherence tomography and digital indocyanine green angiography. It is easy to neglect an ocular symptom that may appear after a low-dose corticosteroid treatment as an ocular complication in patients with Behcet's disease. Thus, we report on a case concerning high-dose corticosteroid treatment with a literature review.

Keywords

References

  1. Kleinberger AJ, Patel C, Lieberman RM, Malkin BD. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature. Laryngoscope 2011;121:2034-7.
  2. Schatz H, Madeira D, Johnson RN, McDonald HR. Central serous chorioretinopathy occurring in patients 60 years of age and older. Ophthalmology 1992;99:63-7. https://doi.org/10.1016/S0161-6420(92)32010-X
  3. Ryan SJ. Retina. 2nd ed. St. Louis: SV Mosby; 1994. p. 1158-68.
  4. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63(3 Suppl):1-139.
  5. Yannuzzi LA, Gitter KA, Schatz H. The macula: a comprehensive text and atlas, 2nd ed. Baltimore: William & Wilkins; 1982. p. 145-65.
  6. Ueoka T. A pathologic study of central serous chorioretinopathy. Acta Soc Ophthalmol Jpn 1949;53:222-6.
  7. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47:431-48. https://doi.org/10.1016/S0039-6257(02)00338-7
  8. Cho WB, Chung H, Kim HC. Spectral domain OCT findings of asymptomatic fellow eyes in central serous chorioretinopathy. J Korean Ophthalmol Soc 2010;51:1345-53. Korean. https://doi.org/10.3341/jkos.2010.51.10.1345
  9. Lafaut BA, Salati C, Priem H, De Laey JJ. Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp Ophthalmol 1998;236:513-21. https://doi.org/10.1007/s004170050114
  10. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-42. https://doi.org/10.1097/00006982-199414030-00008
  11. Taban M, Boyer DS, Thomas EL, Taban M. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004;137:1073-80. https://doi.org/10.1016/j.ajo.2004.01.043
  12. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 1997;41:180-5. https://doi.org/10.1016/S0021-5155(97)00027-0
  13. Chaine G, Haouat M, Menard-Molcard C, Favard C, Vignal-Clermont C, Campinchi-Tardy F, et al. [Central serous chorioretinopathy and systemic steroid therapy]. J Fr Ophtalmol 2001;24:139-46.
  14. Koyama M, Mizota A, Igarashi Y, Adachi-Usami E. Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy. Ophthalmologica 2004;218:107-10. https://doi.org/10.1159/000076145
  15. Loo JL, Lee SY, Ang CL. Can long-term corticosteriods lead to blindness? A case series of central serous chorioretinopathy induced by corticosteroids. Ann Acad Med Singapore 2006;35:496-9.
  16. Levy J, Marcus M, Belfair N, Klemperer I, Lifshitz T. Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy. Can J Ophthalmol 2005;40:217-21. https://doi.org/10.1016/S0008-4182(05)80040-7
  17. Fawzi AA, Holland GN, Kreiger AE, Heckenlively JR, Arroyo JG, Cunningham ET Jr. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology 2006;113:805-13.e5. https://doi.org/10.1016/j.ophtha.2006.01.031
  18. Park WI, Jung HW, Cho JE, You JR. A case of central serous chorioretinopathy associated with systemic corticosteroid treatment of Bell’s palsy. Korean J Otorhinolaryngol-Head Neck Surg 2012;55:458-60. Korean. https://doi.org/10.3342/kjorl-hns.2012.55.7.458
  19. Moon YR, Kim YK, Kim YS, Lee YS. Two cases of central serous chorioretinopathy (CSCR) following corticosteroid therapy for chronic glomerulonephritis. Korean J Med 2008; 75:221-4. Korean.
  20. Quax RA, van Laar JA, van Heerebeek R, Greiner K, Ben- Chetrit E, Stanford M, et al. Glucocorticoid sensitivity in Behcet’s disease. Endocr Connect 2012;1:103-11. https://doi.org/10.1530/EC-12-0056